CPSI Biotech Biotechnology to Move Medicine Forward
CPSI Biotech is a company which has been built
around a three-business approach;
research and development,
intellectual property and
commercialization ventures. The company was established as a research and development organization which dedicated its
focus on minimally invasive cold (low temperature) ablation of benign and malignant cells.
Applied and basic
life science research, medical device design and novel process development are the core of CPSI.
Our interdisciplinary approach to translational research facilitates novel discoveries.
Research and Development Our focus is our strength.
CPSI supports two principal research divisions: Life Science and
Engineering.
While distinct, our research efforts are united by the underlying idea that temperature and
stress responses can be harnessed
and provide a unique insight into biological methods.
Research and Development results in new intellectual property (IP). It is our goal to license the developed IP to a partner for product commercialization,
thereby establishing a revenue stream and bringing discoveries to the next stage.
CPSI Biotech has developed unique Cryotherapy Intellectual Property which may offer viable and safe alternatives to conventional surgery
and radiation treatments. The Company's technology has already been evaluated in animal studies by early adopters in surgical and interventional cardiology,
interventional radiology and urology. Scientific discovery is step one. Contact us to discuss licensing and continuing development of novel IP.
Contact us for more information
Applied and basic
life science research, medical device design and novel process development are the core of CPSI.
CPSI supports two principal research divisions:
